Combination of organic compounds

Details for Australian Patent Application No. 2005294320 (hide)

Owner Novartis AG

Inventors Hughes, Thomas Edward; Burkey, Bryan

Agent Davies Collison Cave

Pub. Number AU-A-2005294320

PCT Pub. Number WO2006/041976

Priority 60/617,201 08.10.04 US

Filing date 6 October 2005

Wipo publication date 20 April 2006

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/401 (2006.01) - Proline

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/041976 Priority application(s): WO2006/041976

7 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005294322-Multivalent avian influenza vaccines

2005294319-Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0)non -1(7)-en-2-yl)alkyl]phosphonic acid and method of making them